한국독성학회:학술대회논문집 (Proceedings of the Korean Society of Toxicology Conference)
- 한국독성학회 2003년도 추계학술대회
- /
- Pages.84-85
- /
- 2003
Pre-Clinical Research with Biotechnology Products
- Berryman, Leigh (President, LAB Pre-Clinical Research International Inc, Canada.)
- 발행 : 2003.10.01
초록
The process of drug development has seen major changes over the last two decades with the movement away from standard small molecule drug discovery programs, through computer-assisted drug design methodologies towards biotechnologically derived products. The aim of duplication of endogenously active materials to be administered exogenously has enormous impact on development practices and evaluation of safety.(omitted)
키워드